Monday - November 16, 2026
Allarta Life Science Moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic with Breakthrough T1D Award
November 16, 2026
NEW YORK, Nov. 16 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Allarta Life Science Moves Canadian-developed Type 1 Diabetes Cell Therapy Closer to the Clinic with Breakthrough T1D Award

*

Announced during Diabetes Awareness Month, the award marks significant progress for type 1 diabetes cell therapies

HAMILTON, Ont., Nov. 16, 2026 - Allarta . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products